186 related articles for article (PubMed ID: 23003125)
1. Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy.
Peterson JA; Kanack A; Nayak D; Bougie DW; McFarland JG; Curtis BR; Aster RH
Transfusion; 2013 Jun; 53(6):1309-18. PubMed ID: 23003125
[TBL] [Abstract][Full Text] [Related]
2. Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia.
Bakchoul T; Kubiak S; Krautwurst A; Roderfeld M; Siebert HC; Bein G; Sachs UJ; Santoso S
Transfusion; 2011 Nov; 51(11):2455-61. PubMed ID: 21564107
[TBL] [Abstract][Full Text] [Related]
3. Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia.
Bakchoul T; Boylan B; Sachs UJ; Bein G; Ruan C; Santoso S; Newman PJ
Transfusion; 2009 Feb; 49(2):265-70. PubMed ID: 19000229
[TBL] [Abstract][Full Text] [Related]
4. Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.
Jackson DJ; Eastlake JL; Kumpel BM
Clin Exp Immunol; 2014 Apr; 176(1):23-36. PubMed ID: 24261689
[TBL] [Abstract][Full Text] [Related]
5. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
Kjeldsen-Kragh J; Bengtsson J
Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
[TBL] [Abstract][Full Text] [Related]
6. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a.
Turner ML; Bessos H; Fagge T; Harkness M; Rentoul F; Seymour J; Wilson D; Gray I; Ahya R; Cairns J; Urbaniak S
Transfusion; 2005 Dec; 45(12):1945-56. PubMed ID: 16371049
[TBL] [Abstract][Full Text] [Related]
7. HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women.
Kjeldsen-Kragh J; Titze TL; Lie BA; Vaage JT; Kjær M
Blood Adv; 2019 Apr; 3(7):945-951. PubMed ID: 30923048
[TBL] [Abstract][Full Text] [Related]
8. Neonatal alloimmune thrombocytopenia caused by anti-HPA antibodies in pregnant Chinese women: a study protocol for a multicentre, prospective cohort trial.
Chen L; Liu Z; Liu T; Ma X; Rao M; Wang Y; Sun B; Yin W; Zhang J; Yan B; Li X; Wang Q; Zhang L; Wen J; Liu F; Wang P; Wei Y; Huang Y; Wu J; Guo Y; Kang Y; Song X; Liu X; Zhang G; Xie T; Chen Y; Zeng X; Li Z
BMC Pregnancy Childbirth; 2017 Aug; 17(1):281. PubMed ID: 28859622
[TBL] [Abstract][Full Text] [Related]
9. Foetal and neonatal alloimmune thrombocytopenia - The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome.
Kjeldsen-Kragh J; Ahlen MT
Transfus Apher Sci; 2020 Feb; 59(1):102707. PubMed ID: 31919011
[TBL] [Abstract][Full Text] [Related]
10. HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.
Wienzek-Lischka S; König IR; Papenkort EM; Hackstein H; Santoso S; Sachs UJ; Bein G
Transfusion; 2017 Mar; 57(3):533-540. PubMed ID: 28019029
[TBL] [Abstract][Full Text] [Related]
11. Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology.
Socher I; Andrei-Selmer C; Bein G; Kroll H; Santoso S
Transfusion; 2009 May; 49(5):943-52. PubMed ID: 19175553
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR-DQ haplotypes.
Ahlen MT; Heide G; Husebekk A; Skogen B; Kjeldsen-Kragh J; Stuge TB
Scand J Immunol; 2020 Jul; 92(1):e12890. PubMed ID: 32299122
[TBL] [Abstract][Full Text] [Related]
13. T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cells.
Ahlen MT; Husebekk A; Killie MK; Skogen B; Stuge TB
Blood; 2009 Apr; 113(16):3838-44. PubMed ID: 19136661
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.
Bakchoul T; Greinacher A; Sachs UJ; Krautwurst A; Renz H; Harb H; Bein G; Newman PJ; Santoso S
Blood; 2013 Jul; 122(3):321-7. PubMed ID: 23645838
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn.
Killie MK; Husebekk A; Kjeldsen-Kragh J; Skogen B
Haematologica; 2008 Jun; 93(6):870-7. PubMed ID: 18443267
[TBL] [Abstract][Full Text] [Related]
16. Maternal incompatibilities with fetal human platelet alloantigens -1a, -1b and -15 are the main causes of neonatal alloimmune thrombocytopenia in Russia.
Khaspekova SG; Golovkina LL; Donush EK; Golubeva NV; Shustova ON; Mazurov AV
Ter Arkh; 2018 Aug; 90(7):65-69. PubMed ID: 30701924
[TBL] [Abstract][Full Text] [Related]
17. The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes.
Ahlen MT; Husebekk A; Killie MK; Kjeldsen-Kragh J; Olsson ML; Skogen B
Clin Dev Immunol; 2012; 2012():156867. PubMed ID: 22110529
[TBL] [Abstract][Full Text] [Related]
18. Maternal HLA genotyping is not useful for predicting severity of fetal and neonatal alloimmune thrombocytopenia.
Sainio S; Javela K; Tuimala J; Haimila K
Br J Haematol; 2017 Jan; 176(1):111-117. PubMed ID: 27748520
[TBL] [Abstract][Full Text] [Related]
19. What's happening? The expanding role of apheresis platelet support in neonatal alloimmune thrombocytopenia: current status and future trends.
Bessos H; Seghatchian J
Transfus Apher Sci; 2005 Oct; 33(2):191-7. PubMed ID: 16140039
[TBL] [Abstract][Full Text] [Related]
20. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
